Education
About Us
Working with TipRanks
Follow Us
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 49.72M | $ 17.50M | $ 27.76M | $ 240.03M | $ 263.70M |
| Gross Profit | $ 40.27M | $ 13.88M | $ 24.47M | $ 128.40M | $ 121.75M |
| Operating Income | $ -58.99M | $ -78.71M | $ -61.74M | $ -280.69M | $ 5.68M |
| EBITDA | $ -48.23M | $ -71.32M | $ -69.67M | $ -222.80M | $ -16.28M |
| Net Income | $ -51.69M | $ -64.92M | $ -79.59M | $ -270.90M | $ -109.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 44.54M | $ 43.51M | $ 114.05M | $ 95.86M | $ 70.83M |
| Total Assets | $ 128.51M | $ 144.67M | $ 370.95M | $ 463.25M | $ 827.14M |
| Total Debt | $ 57.49M | $ 47.65M | $ 221.62M | $ 273.30M | $ 268.83M |
| Net Debt | $ 12.95M | $ 7.20M | $ 107.56M | $ 177.43M | $ 198.00M |
| Total Liabilities | $ 77.42M | $ 67.94M | $ 277.09M | $ 348.55M | $ 443.30M |
| Stockholders' Equity | $ 51.09M | $ 76.73M | $ 93.86M | $ 114.71M | $ 383.85M |
| Cash Flow | |||||
| Free Cash Flow | $ -38.56M | $ -56.51M | $ 14.46M | $ 29.53M | $ 33.41M |
| Operating Cash Flow | $ -37.81M | $ -54.73M | $ 17.59M | $ 33.57M | $ 37.56M |
| Investing Cash Flow | $ 126.00K | $ 116.45M | $ -3.08M | $ -4.02M | $ -4.13M |
| Financing Cash Flow | $ 41.78M | $ -135.33M | $ 3.68M | $ -4.69M | $ 3.60M |
RVL Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.